Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Gynecologic Oncology
|
May 24, 2001
Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells
M Cuello, S A Ettenberg, M M Nau, et al.
Cancer Research
|
October 15, 1996
Fas expression and function in normal and malignant breast cell lines
M M Keane, S A Ettenberg, G A Lowrey, et al.
Cancer Research
|
September 15, 1996
The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells
M M Keane, G A Lowrey, S A Ettenberg, et al.
Cancer Research
|
February 11, 1999
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
M M Keane, S A Ettenberg, M M Nau, et al.
Molecular Cell Biology Research Communications : MCBRC
|
November 5, 1999
cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors
S A Ettenberg, Y R Rubinstein, P Banerjee, et al.
Breast Cancer Research and Treatment
|
February 24, 2001
Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines
M M Keane, Y Rubinstein, M Cuello, et al.
Oncogene
|
June 11, 1999
cbl-3: a new mammalian cbl family protein
M M Keane, S A Ettenberg, M M Nau, et al.
Oncogene
|
March 23, 1999
cbl-b inhibits epidermal growth factor receptor signaling
S A Ettenberg, M M Keane, M M Nau, et al.
The Journal of Biological Chemistry
|
May 26, 2001
Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex
S A Ettenberg, A Magnifico, M Cuello, et al.
Cancer Research
|
June 19, 2001
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2
M Cuello, S A Ettenberg, A S Clark, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Gynecologic Oncology
|
May 24, 2001
Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells
M Cuello, S A Ettenberg, M M Nau, et al.
Cancer Research
|
October 15, 1996
Fas expression and function in normal and malignant breast cell lines
M M Keane, S A Ettenberg, G A Lowrey, et al.
Cancer Research
|
September 15, 1996
The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells
M M Keane, G A Lowrey, S A Ettenberg, et al.
Cancer Research
|
February 11, 1999
Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
M M Keane, S A Ettenberg, M M Nau, et al.
Molecular Cell Biology Research Communications : MCBRC
|
November 5, 1999
cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors
S A Ettenberg, Y R Rubinstein, P Banerjee, et al.
Breast Cancer Research and Treatment
|
February 24, 2001
Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines
M M Keane, Y Rubinstein, M Cuello, et al.
Oncogene
|
June 11, 1999
cbl-3: a new mammalian cbl family protein
M M Keane, S A Ettenberg, M M Nau, et al.
Oncogene
|
March 23, 1999
cbl-b inhibits epidermal growth factor receptor signaling
S A Ettenberg, M M Keane, M M Nau, et al.
The Journal of Biological Chemistry
|
May 26, 2001
Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex
S A Ettenberg, A Magnifico, M Cuello, et al.
Cancer Research
|
June 19, 2001
Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2
M Cuello, S A Ettenberg, A S Clark, et al.
Page
of 2